Viatris

Halal Rating :
Uncomfortable
Last Price $10.7
Market Cap $12.81b
1D Change

-1.65 %

1 Year Change

-12.56 %

Next Earnings Date

Yet to be announced

Company Overview

Viatris Inc. is a global pharmaceutical company formed in 2020 through the merger of Mylan and Upjohn, a former division of Pfizer. The company develops, manufactures, and distributes generic, branded generic, brand-name, and biosimilar drugs and active pharmaceutical ingredients. Their portfolio includes products across various therapeutic areas including cardiovascular, infectious disease, oncology, immunology, central nervous system, and diabetes.

Revenue Sources

Pass

After reviewing Viatris's product portfolio and revenue streams, their primary revenue comes from pharmaceutical products and healthcare solutions. None of their major revenue sources involve prohibited activities or products like alcohol, tobacco, gambling, or adult entertainment. Their business model focuses on developing and distributing medicines and healthcare products, which are permissible activities from an Islamic perspective.

Reliance on Interest

Reporting Date Total Revenue Total Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $3.75b $3.67b - $145.6m 0.00% 3.97%
June 30, 2024 $3.8b $4.18b - $145.8m 0.00% 3.49%
March 31, 2024 $3.66b $3.6b - $138.4m 0.00% 3.85%
Dec. 31, 2023 $3.84b $4.43b - $140.9m 0.00% 3.18%

Based on the financial data from the last four quarters: Interest expense to total expense ratios have been consistently above the 5% threshold, ranging from approximately 3.3% to 4% of total expenses. This indicates that interest plays a material role in the company's operations.

Operational Ethics

Pass

Viatris maintains operations globally but careful review of their public disclosures and operations does not reveal any material ongoing associations with entities involved in human rights violations. While the company does business in various markets including China, there is no evidence of direct material ties to the Chinese Communist Party. Additionally, no significant operations or R&D centers were found in Israel.

Rating Justification

Member Vote

Agree: 0 Disagree: 0

Login to vote on this

Comments

0 Comments

Login to join the discussion

Recent News & Updates